Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.

Yatham, Lakshmi N; Vieta, Eduard; Goodwin, Guy M; Bourin, Michel; de Bodinat, Christian; Laredo, Judith; Calabrese, Joseph

Yatham, Lakshmi N; Vieta, Eduard; Goodwin, Guy M; Bourin, Michel; de Bodinat, Christian; Laredo, Judith; Calabrese, Joseph.

Afiliación

Yatham LN; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O
Vieta E; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O
Goodwin GM; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O
Bourin M; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O
de Bodinat C; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O
Laredo J; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O
Calabrese J; Lakshmi N. Yatham, MBBS, University of British Columbia, Vancouver, British Columbia, Canada; Eduard Vieta, MD, Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; Guy M. Goodwin, MD, University Department of Psychiatry, O

Br J Psychiatry ; 208(1): 78-86, 2016 Jan.

Article en En | MEDLINE | ID: mdl-25999335

Asunto(s)

Acetamidas/administración & dosificación; Antidepresivos/administración & dosificación; Trastorno Bipolar/tratamiento farmacológico; Efecto Placebo; Acetamidas/efectos adversos; Adulto; Antidepresivos/efectos adversos; Antimaníacos/uso terapéutico; Argentina; Australia; Trastorno Bipolar/diagnóstico; Brasil; Canadá; Método Doble Ciego; Quimioterapia Combinada; Europa (Continente); Femenino; Humanos; India; Cooperación Internacional; Compuestos de Litio/uso terapéutico; Masculino; Persona de Mediana Edad; Escalas de Valoración Psiquiátrica; República de Corea; Sudáfrica; Resultado del Tratamiento; Ácido Valproico/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno Bipolar / Efecto Placebo / Acetamidas / Antidepresivos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa / America do norte / America do sul / Argentina / Asia / Brasil / Europa / Oceania Idioma: En Revista: Br J Psychiatry Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google